Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Schmidt

Showing results (251-260 of 319) with videos related to

Pageof 32
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 3, 2017
Quality assurance guidelines for superficial hyperthermia clinical trials : II. Technical requirements for heating devicesHana Dobšíček Trefná, Johannes Crezee, Manfred Schmidt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activityClaudia A Montiel-Equihua, Lin Zhang, Sean Knight, et al.
Gene Therapy|May 5, 2022
HIV- 1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survivalSaqlain Suleman, Annette Payne, Johnathan Bowden, et al.
Human Gene Therapy Methods|March 21, 2012
Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapyMudita Pincha, Bala Sai Sundarasetty, Gustavo Salguero, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 21, 2014
Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivoDaniela Cesana, Marco Ranzani, Monica Volpin, et al.
The New England Journal of Medicine|November 12, 2010
Stem-cell gene therapy for the Wiskott-Aldrich syndromeKaan Boztug, Manfred Schmidt, Adrian Schwarzer, et al.
Gene Therapy|July 15, 2025
<sup>h</sup>InGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicitySaqlain Suleman, Sharmin Alhaque, Andrew Guo, et al.
Leukemia|May 22, 2021
The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decisionFriederike Herbst, Tonio J L Lang, Elias S P Eckert, et al.
Cell|April 25, 2006
A hybrid vector for ligand-directed tumor targeting and molecular imagingAmin Hajitou, Martin Trepel, Caroline E Lilley, et al.
British Journal of Haematology|September 17, 2013
Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemiaAlexander Jethwa, Jennifer Hüllein, Tatjana Stolz, et al.
Pageof 32

Showing results (251-260 of 319) with videos related to

Sort By:
Pageof 32
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 3, 2017
Quality assurance guidelines for superficial hyperthermia clinical trials : II. Technical requirements for heating devicesHana Dobšíček Trefná, Johannes Crezee, Manfred Schmidt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activityClaudia A Montiel-Equihua, Lin Zhang, Sean Knight, et al.
Gene Therapy|May 5, 2022
HIV- 1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survivalSaqlain Suleman, Annette Payne, Johnathan Bowden, et al.
Human Gene Therapy Methods|March 21, 2012
Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapyMudita Pincha, Bala Sai Sundarasetty, Gustavo Salguero, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 21, 2014
Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivoDaniela Cesana, Marco Ranzani, Monica Volpin, et al.
The New England Journal of Medicine|November 12, 2010
Stem-cell gene therapy for the Wiskott-Aldrich syndromeKaan Boztug, Manfred Schmidt, Adrian Schwarzer, et al.
Gene Therapy|July 15, 2025
<sup>h</sup>InGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicitySaqlain Suleman, Sharmin Alhaque, Andrew Guo, et al.
Leukemia|May 22, 2021
The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decisionFriederike Herbst, Tonio J L Lang, Elias S P Eckert, et al.
Cell|April 25, 2006
A hybrid vector for ligand-directed tumor targeting and molecular imagingAmin Hajitou, Martin Trepel, Caroline E Lilley, et al.
British Journal of Haematology|September 17, 2013
Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemiaAlexander Jethwa, Jennifer Hüllein, Tatjana Stolz, et al.
Pageof 32